Answer
This question has not yet been answered.
Monoferric must be administered by a healthcare professional as an IV iron product, not self-administered. It should be given in a setting where staff and emergency treatment for anaphylaxis/hypersensitivity are immediately available.
Typical U.S. label administration:
For adults ≥50 kg: give 1,000 mg IV infusion as a single dose over at least 20 minutes.
For adults <50 kg: give 20 mg/kg actual body weight IV infusion over at least 20 minutes. Repeat only if iron deficiency anemia recurs.
Preparation:
Withdraw the required dose and dilute in 100–500 mL of 0.9% sodium chloride. Final concentration should be >1 mg iron/mL. Do not mix Monoferric with other drugs, and discard unused vial contents because vials are single-dose.
Monitoring and safety:
Monitor for hypersensitivity during the infusion and for at least 30 minutes afterward, until clinically stable. It should only be administered where personnel and therapies for serious hypersensitivity reactions are available. Avoid use in patients with prior serious hypersensitivity to Monoferric or iron overload.
Canada note: The Canadian product monograph also describes administration by IV drip infusion, IV bolus injection, or directly into the venous limb of the dialyzer during hemodialysis. For IV infusion, doses ≤1000 mg are given over 20 minutes, and doses >1000 mg over 30 minutes; single doses above 1500 mg are not recommended.
Do you have the same question? Follow this Question
This question has not yet been answered.
View all Monoferric (Ferric Derisomaltose) Questions & Answers